Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia.

Subherwal S, Anstrom KJ, Jones WS, Felker MG, Misra S, Conte MS, Hiatt WR, Patel MR.

Am Heart J. 2012 Sep;164(3):277-84. doi: 10.1016/j.ahj.2012.07.002. No abstract available.

2.

Composite End Points in Clinical Research: A Time for Reappraisal.

Armstrong PW, Westerhout CM.

Circulation. 2017 Jun 6;135(23):2299-2307. doi: 10.1161/CIRCULATIONAHA.117.026229. Review.

PMID:
28584030
3.

Improved amputation-free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement.

Benoit E, O'Donnell TF Jr, Kitsios GD, Iafrati MD.

J Vasc Surg. 2012 Mar;55(3):781-9. doi: 10.1016/j.jvs.2011.10.089. Epub 2011 Dec 29. Review.

4.

Equivalence approaches.

Williams RL, Chen ML, Hauck WW.

Clin Pharmacol Ther. 2002 Sep;72(3):229-37. Review. No abstract available.

PMID:
12235443
5.

End points in advanced colon cancer clinical trials: a review and proposal.

Allegra C, Blanke C, Buyse M, Goldberg R, Grothey A, Meropol NJ, Saltz L, Venook A, Yothers G, Sargent D.

J Clin Oncol. 2007 Aug 20;25(24):3572-5. Review. No abstract available.

PMID:
17704403
6.

Critical limb ischemia: cell and molecular therapies for limb salvage.

Davies MG.

Methodist Debakey Cardiovasc J. 2012 Oct-Dec;8(4):20-7. Review.

7.

Non-invasive treatment of critical limb ischemia.

Diehm C, Diehm N.

Curr Drug Targets Cardiovasc Haematol Disord. 2004 Sep;4(3):241-7. Review.

PMID:
15379616
8.

Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.

Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW.

J Am Coll Cardiol. 2011 Jan 18;57(3):253-69. doi: 10.1016/j.jacc.2010.12.005. Epub 2011 Jan 7.

9.

The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention.

Kip KE, Hollabaugh K, Marroquin OC, Williams DO.

J Am Coll Cardiol. 2008 Feb 19;51(7):701-7. doi: 10.1016/j.jacc.2007.10.034. Review.

10.

Regenerative medicine in critical limb ischemia.

Ohno T, Kaneda H, Nagai Y, Fukushima M.

J Atheroscler Thromb. 2012;19(10):883-9. Epub 2012 Jun 8. Review.

11.

[Non-surgical treatment of critical limb ischemia].

Stephan D, Griffon C, Welsch M, Boila S, Fend E.

Ann Cardiol Angeiol (Paris). 2007 Apr;56(2):70-3. Review. French.

PMID:
17484090
12.

Understanding objective performance goals for critical limb ischemia trials.

Conte MS.

Semin Vasc Surg. 2010 Sep;23(3):129-37. doi: 10.1053/j.semvascsurg.2010.06.001. Review.

PMID:
20826289
13.

The Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future use.

Barnes PJ, Casale TB, Dahl R, Pavord ID, Wechsler ME.

Allergy. 2014 Sep;69(9):1119-40. doi: 10.1111/all.12415. Epub 2014 Jul 15. Review.

PMID:
25039248
14.

In the end what matters most? A review of clinical endpoints in advanced breast cancer.

Verma S, McLeod D, Batist G, Robidoux A, Martins IR, Mackey JR.

Oncologist. 2011;16(1):25-35. doi: 10.1634/theoncologist.2010-0278. Epub 2011 Jan 6. Review.

15.

Outcome Reporting in Cardiac Surgery Trials: Systematic Review and Critical Appraisal.

Goldfarb M, Drudi L, Almohammadi M, Langlois Y, Noiseux N, Perrault L, Piazza N, Afilalo J.

J Am Heart Assoc. 2015 Aug 17;4(8):e002204. doi: 10.1161/JAHA.115.002204. Review.

16.

End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives.

Hoeper MM, Oudiz RJ, Peacock A, Tapson VF, Haworth SG, Frost AE, Torbicki A.

J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):48S-55S. Review.

17.

[Treatment perspectives for critical limb ischemia: gene and cell therapy].

Pasqualoni E, Messas E, Fiessinger JN, Emmerich J.

Presse Med. 2008 Jun;37(6 Pt 2):1039-46. doi: 10.1016/j.lpm.2008.02.009. Epub 2008 May 2. Review. French.

PMID:
18450413
18.

[Therapeutic angiogenesis of critical lower limb ischemia. Review of the literature and prospects of research on stem cells].

Di Stefano R, Limbruno U, Barone D, Balbarini A.

Ital Heart J Suppl. 2004 Jan;5(1):1-13. Review. Italian.

PMID:
15253139
19.

GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.

Levey AS, Inker LA, Matsushita K, Greene T, Willis K, Lewis E, de Zeeuw D, Cheung AK, Coresh J.

Am J Kidney Dis. 2014 Dec;64(6):821-35. doi: 10.1053/j.ajkd.2014.07.030. Epub 2014 Oct 16. Review.

PMID:
25441437
20.

[Endovascular therapy for critical limb ischemia].

Sumi M, Ohki T.

Nihon Geka Gakkai Zasshi. 2007 Jul;108(4):194-8. Review. Japanese.

PMID:
17665559

Supplemental Content

Support Center